Kenneth Rosenzweig, MD, Joins Mount Sinai School of Medicine
Lung cancer specialist Kenneth Rosenzweig, MD has been appointed Chair of the Department of Radiation Oncology at Mount Sinai School of Medicine.
Kenneth Rosenzweig, MD, a renowned physician-scientist who specializes in treating lung cancer and malignant mesothelioma, has been appointed Chair of the Department of Radiation Oncology at Mount Sinai School of Medicine. His appointment is effective on June 1.
“We are pleased to have attracted such an esteemed innovator in the field of radiation oncology," said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs at The Mount Sinai Medical Center. “Dr. Rosenzweig’s expertise with novel technologies in treating thoracic malignancies will be an asset to Mount Sinai."
Dr. Rosenzweig is a pioneer in the development of innovative methods for the delivery of precise doses of radiation to lung tumors during certain points in the respiration cycle, allowing physicians to safely increase the radiation dose, shorten treatment and spare healthy tissue. He has also worked to incorporate positron emission tomography (PET), an imaging procedure that produces advanced biological images of the body, into the radiation treatment.
A groundbreaking researcher in radiation therapy, Dr. Rosenzweig was the principal investigator for a critical-dose escalation study that established the maximum tolerated dose of radiation therapy that can be safely delivered. He has published more than 70 articles in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology Biology Physics and Radiotherapy Oncology. He has authored numerous textbook chapters, including chapters in Principles and Practice of Oncology, the leading textbook of cancer medicine.
In addition to his extensive research background, Dr. Rosenzweig has served on many professional committees, including the Radiation Therapy Oncology Group (RTOG) Lung Committee, the RTOG Data Monitoring Committee and the National Cancer Institute Clinical Trails Evaluation Panel. He has also served as a consultant to the International Atomic Energy Association. An accomplished educator, he was named "Teacher of the Year" by the Association of Residents in Radiation Oncology.
After receiving his medical degree from the Yale University School of Medicine in 1992, Dr. Rosenzweig continued his training as a medical intern at Beth Israel Hospital in Boston and his residency at the Joint Center for Radiation Therapy at Harvard Medical School. He has worked at Memorial Sloan-Kettering Cancer Center since completing his training in 1997.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 60,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 60,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.
Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants. For more information, please visit www.mountsinai.org.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube.